Medicine

Farzad Moazed, MD

Assistant Professor
Medicine

Nhung Nguyen, PhD

Postdoctoral Scholar
Medicine

Nhung Nguyen received her PhD in Epidemiology from The University of Texas Health Science Center at Houston, TX, and her BS in Pharmacy from Hanoi University of Pharmacy, Vietnam. Her dissertation was among the first to examine smoking prevalence, nicotine dependence, and related factors among HIV-positive people in Vietnam. Her research interests include application of technology and data science in smoking cessation intervention among smokers with polysubstance use, and in smoking prevention among youth and young adults. 

Julia Mcquoid, PhD

Postdoc Scholar
Medicine

I am a health geographer interested in qualitative and mixed methods approaches to understanding relationships between people’s everyday environments and behaviors related to health and wellbeing. During my fellowship at the Center for Tobacco Control Research and Education at UCSF, I am researching place-embedded social practices of smoking within marginalized groups, such as young LGBTQI adults, in order to better understand the persistence of smoking within these groups and inform the design and effectiveness of tobacco control efforts.

Prescott Woodruff, MD

Professor
Medicine

Research program includes clinical and basic science approaches to study the effects of cigarette smoke on lung inflammation. He is also the Principal Investigator on the NIH-funded Spiromics Project and a Co-investigator on the COPD Clinical Research Network. Dr. Woodruff received his B.A, from Wesleyan University in 1989, received his M.D. degree from the Columbia College of Physicians and Surgeons in 1993, and completed Internal Medicine residency training at the Massachusetts General Hospital.

Maya Vijayaraghavan, MD, MAS

Assistant Professor
Medicine

My research focuses on tobacco use in vulnerable populations, with a particular emphasis on interventions with the homeless population. My population-based research includes the analysis of cross-sectional and longitudinal data, including the analysis of national data, to examine the use of novel tobacco products and the efficacy of tobacco control policies on reducing tobacco use in low-income populations.

Gideon St Helen, PhD

Assistant Professor
Medicine

The focus of my research program in the Division of Clinical Pharmacology, as shown in the image below, is the utility and evaluation of biological markers (biomarkers) of tobacco use and exposure for epidemiology, risk assessment, product regulation, and identification of susceptibility factors.

Research Themes Visual- information below

Matthew Springer, PhD

Professor
Medicine

RESEARCH INTERESTS:

Dr. Matthew L. Springer received his BA from the University of California, Berkeley in 1985 and his PhD from Stanford University in 1992. He did postdoctoral research at Stanford and continued his research there as a senior scientist until joining the UCSF faculty in 2003, where he is currently one of two non-clinicians on the faculty of the Division of Cardiology. The close juxtaposition of his basic research background with the clinical cardiologists in the Division has resulted in an active translational research program.

Joel Simon, MD, MPH

Professor Emeritus
Medicine

Research has centered on hospital-based and out-patient clinical trials of smoking cessation. Completed studies include: Transdermal Nicotine Therapy for Hospitalized Smokers and Bupropion for Hospital-Based Smoking Cessation.    Dr.

Steve Schroeder, MD

Professor
Medicine

Dr. Schroeder is Distinguished Professor of Health and Health Care, Division of General Internal Medicine, Department of Medicine, UCSF, where he also heads the Smoking Cessation Leadership Center. The Center, funded by the Robert Wood Johnson Foundation and the Truth Initiative, works with leaders of more than 80 American health professional organizations and health care institutions to increase the cessation rate for smokers.

Suzaynn Schick, PhD

Associate Professor
M_MED-ZSFG-OCCM

I study the health effects of air pollution in human subjects. I focus on the chemistry and toxicity of smoke and on how exposure to cigarette smoke can cause heart and lung disease. My analysis of tobacco industry research showed that sidestream cigarette smoke (the primary constituent of secondhand cigarette smoke) is more toxic than the smoke that smokers inhale and that secondhand smoke becomes more toxic as it ages.

Pages